🔗 Share this article

The top legal official in Texas Ken Paxton is suing the producers of acetaminophen, claiming the corporations withheld potential risks that the medication posed to children's neurological development.

This legal action arrives thirty days after President Donald Trump publicized an unproven link between taking Tylenol - alternatively called acetaminophen - during pregnancy and autism spectrum disorder in offspring.

The attorney general is taking legal action against the pharmaceutical giant, which formerly manufactured the medication, the sole analgesic approved for expectant mothers, and Kenvue, which now manufacturers it.

In a declaration, he stated they "misled consumers by profiting off of suffering and pushing pills ignoring the risks."

The manufacturer says there is insufficient reliable data linking Tylenol to autism spectrum disorder.

"These companies lied for decades, knowingly endangering countless individuals to increase profits," Paxton, from the Republican party, stated.

The manufacturer commented that it was "seriously troubled by the perpetuation of misinformation on the reliability of acetaminophen and the potential impact that could have on the health of women and children in America."

On its official site, the company also stated it had "continuously evaluated the relevant science and there is insufficient valid information that indicates a proven link between consuming paracetamol and autism spectrum disorder."

Organizations representing doctors and medical practitioners share this view.

ACOG has declared paracetamol - the key substance in Tylenol - is among limited choices for expectant mothers to treat pain and elevated temperature, which can pose serious health risks if ignored.

"In multiple decades of studies on the use of paracetamol in gestation, zero credible investigations has successfully concluded that the use of acetaminophen in any trimester of pregnancy leads to brain development issues in young ones," the group commented.

The court filing mentions recent announcements from the Trump administration in asserting the medication is potentially dangerous.

Recently, Trump caused concern from medical authorities when he instructed pregnant women to "struggle intensely" not to consume acetaminophen when sick.

The FDA then published an announcement that physicians should contemplate reducing the usage of acetaminophen, while also stating that "a proven link" between the drug and autism spectrum disorder in minors has not been proven.

Health Secretary Robert F Kennedy Jr, who oversees the Food and Drug Administration, had vowed in spring to initiate "comprehensive study program" that would determine the cause of autism in a limited time.

But authorities advised that discovering a sole reason of autism - considered by experts to be the result of a complex mix of inherited and environmental factors - would be difficult.

Autism spectrum disorder is a form of lifelong neurodivergence and condition that impacts how people experience and relate to the world, and is diagnosed using medical professional evaluations.

In his legal document, Paxton - who supports Trump who is running for federal office - asserts the manufacturer and J&J "deliberately disregarded and attempted to silence the research" around paracetamol and autism.

This legal action seeks to make the companies "destroy any promotional materials" that states Tylenol is safe for women during pregnancy.

The court case parallels the grievances of a assembly of guardians of minors with autism and attention deficit hyperactivity disorder who sued the manufacturers of acetaminophen in 2022.

Judicial authorities dismissed the lawsuit, saying research from the plaintiffs' authorities was lacking definitive proof.